galantamine
PolandDrugs containing this active substance
-
The medicinal product is used for the symptomatic supportive treatment of neuromuscular and spinal neurological diseases.
Form: solution for injection
Active substance Dosage galantamine 5 mg/ml ATC: N07AA
Manufacturer: SOPHARMA AD
-
It is used as adjunctive symptomatic treatment for neurological diseases affecting the spinal cord and neuromuscular diseases.
Form: solution for injection
Active substance Dosage galantamine 5 mg/ml ATC: N07AA
Manufacturer: SOPHARMA AD
-
The drug is used for the supportive, symptomatic treatment of neuromuscular and spinal neurological diseases.
Form: solution for injection
Active substance Dosage galantamine 2.5 mg/ml ATC: N07AA
Manufacturer: SOPHARMA AD
-
The drug is used for the symptomatic, supportive treatment of neurological diseases, spinal cord diseases, and neuromuscular diseases.
Form: solution for injection
Active substance Dosage galantamine 2.5 mg/ml ATC: N07AA
Manufacturer: SOPHARMA AD
-
The medicinal product is used for the symptomatic, supportive treatment of neuromuscular and spinal neurological diseases.
Form: solution for injection
Active substance Dosage galantamine 5 mg/ml ATC: N06DA04
Manufacturer: Sopharma AD
-
The medicinal product is used for the symptomatic, supportive treatment of neurological diseases affecting the spinal cord and neuromuscular diseases.
Form: solution for injection
Active substance Dosage galantamine 5 mg/ml ATC: N06DA04
Manufacturer: SOPHARMA AD
-
The medicinal product is used for the symptomatic, supportive treatment of neuromuscular and spinal neurological diseases.
Form: solution for injection
Active substance Dosage galantamine 5 mg/ml ATC: N07AA
Manufacturer: Sopharma AD